Company Profiles

driven by the PitchBook Platform

Aprecia Pharmaceuticals

Description

Developer of high dose pharmaceuticals to treat central nervous system disorders. The company engages in the development, manufacturing and marketing of fast melt pharmaceutical products via advanced three-dimensional printing which can be used to treat epilepsy and other central nervous system disorders

2003

Founded

PRIVATE

Status

51-200

Employees

Debt

Latest Deal Type

$20M

Latest Deal Amount

$157M

Total Amount Raised

Description

Developer of high dose pharmaceuticals to treat central nervous system disorders. The company engages in the development, manufacturing and marketing of fast melt pharmaceutical products via advanced three-dimensional printing which can be used to treat epilepsy and other central nervous system disorders

Website:

www.aprecia.com

Ownership Status

Privately Held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Delivery

Other Industries

Drug Discovery
Pharmaceuticals

Primary Office

2010 Cabot Boulevard West Suite F Langhorne, PA 19047United States +1 (513) 984-5000
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Aprecia Pharmaceuticals's full profile, request a free trial.

    Aprecia Pharmaceuticals Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Aprecia Pharmaceuticals Cap Table

    Stock# of Shares
    Authorized
    Par ValueDividend Rate (%)Original
    Issue Price
    LiquidationLiquidation
    Pref. Multiple
    Conversion
    Price
    % Owned

    Aprecia Pharmaceuticals Investors (6)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Alpha Capital PartnersPE/BuyoutMinority000 0000000 0000
    Ben Franklin Technology Partners of Southeastern PennsylvaniaOtherMinority000 0000000 0000
    Blue Chip VentureVenture CapitalMinority000 0000000 0000
    Deerfield ManagementVenture CapitalMinority000 0000000 0000
    Hercules CapitalVenture CapitalMinority000 0000000 0000
    Alpha Capital Partners PE/Buyout
    Ben Franklin Technology Partners of Southeastern Pennsylvania Other
    Blue Chip Venture Venture Capital
    Deerfield Management Venture Capital
    Hercules Capital Venture Capital

    Aprecia Pharmaceuticals Executive Team (12)

    NameTitleBoard
    Seat
    Contact
    Info
    Donald WetherholdChief Executive Officer
    Michael RohlfsChief Financial Officer
    Robert WillifordChief Operating Officer
    Aymsley ToomerDirector, Marketing Projects
    Tom BradburyDirector, Process Automation
    Donald Wetherhold Chief Executive Officer
    Michael Rohlfs Chief Financial Officer
    Robert Williford Chief Operating Officer
    Aymsley Toomer Director, Marketing Projects
    Tom Bradbury Director, Process Automation

    Aprecia Pharmaceuticals Board Members (2)

    NameRepresentingRoleSinceContact
    Info
    E. AringtonSelfChairman000 0000
    Lawrence GlassmannSelfBoard Member000 0000
    E. Arington Chairman Self
    Lawrence Glassmann Board Member Self
    Request full access to PitchBook